UTX inhibition as selective epigenetic therapy against TAL1-driven T-cell acute lymphoblastic leukemia.
Benyoucef A, Palii CG, Wang C, Porter CJ, Chu A, Dai F, Tremblay V, Rakopoulos P, Singh K, Huang S, Pflumio F, Hébert J, Couture JF, Perkins TJ, Ge K, Dilworth FJ, Brand M.
Benyoucef A, et al. Among authors: palii cg.
Genes Dev. 2016 Mar 1;30(5):508-21. doi: 10.1101/gad.276790.115.
Genes Dev. 2016.
PMID: 26944678
Free PMC article.